tert-Butyl 1,9-diazaspiro[5.5]undecane-9-carboxylate oxalate
95%
- Product Code: 123740
CAS:
2177259-22-0
| Molecular Weight: | 344.41 g./mol | Molecular Formula: | C₁₆H₂₈N₂O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of complex molecules, particularly in the synthesis of spirocyclic compounds, which are of significant interest due to their structural complexity and potential biological activity. The tert-butyl group provides steric protection, aiding in the selective modification of the molecule during synthetic processes. Additionally, the oxalate salt form enhances its stability and solubility, making it easier to handle and purify in laboratory settings. Its applications extend to the design of drug candidates, especially in the exploration of new therapeutic agents targeting neurological and metabolic disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $700.37 |
+
-
|
| 0.250 | 10-20 days | $1,278.59 |
+
-
|
tert-Butyl 1,9-diazaspiro[5.5]undecane-9-carboxylate oxalate
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of complex molecules, particularly in the synthesis of spirocyclic compounds, which are of significant interest due to their structural complexity and potential biological activity. The tert-butyl group provides steric protection, aiding in the selective modification of the molecule during synthetic processes. Additionally, the oxalate salt form enhances its stability and solubility, making it easier to handle and purify in laboratory settings. Its applications extend to the design of drug candidates, especially in the exploration of new therapeutic agents targeting neurological and metabolic disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :